OBALON THERAPEUTICS INC·4

Jan 4, 4:17 PM ET

Rasdal Andrew P 4

4 · OBALON THERAPEUTICS INC · Filed Jan 4, 2018

Insider Transaction Report

Form 4
Period: 2018-01-02
Rasdal Andrew P
DirectorPresident & CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-01-02+300,000300,000 total
    Exercise: $7.15Exp: 2028-01-02Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date.

Documents

1 file
  • 4
    marketforms-40637.xmlPrimary

    PRIMARY DOCUMENT